Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (11)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Trapani, S.
Right arrow Articles by Falcini, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Trapani, S.
Right arrow Articles by Falcini, F.
Related Collections
Right arrow Myositis and Muscle Disease
Right arrow Dermatomyositis and Polymyositis
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Rheumatology 2001; 40: 216-220
© 2001 British Society for Rheumatology

Paediatric Rheumatology

Pulmonary involvement in juvenile dermatomyositis: a two-year longitudinal study

Paediatric Rheumatology/Series Editor: P. Woo

S. Trapani, G. Camiciottoli1, A. Vierucci, M. Pistolesi1 and F. Falcini

Department of Paediatrics, Rheumatology Unit and
1 Department of Critical Care, Respiratory Unit, University of Florence, Italy

Abstract

Objective. To investigate the prevalence and features of asymptomatic pulmonary involvement in juvenile dermatomyositis (JDM).

Methods. Twelve JDM patients underwent pulmonary function tests at baseline, 12 and 24 months. Disease activity, duration, serum lactate dehydrogenase (LDH) values and antinuclear antibody (ANA) titres were also evaluated.

Results. Five patients showed lung impairment at baseline and four at 12 and 24 months. Forced expiratory volume in 1s, forced vital capacity (FVC), carbon monoxide diffusing capacity (DLCO) and alveolar volume were the most frequently altered variables, indicating a restrictive pattern and impairment of diffusion. The prevalence and features of pulmonary alterations did not change during follow-up. FVC values were significantly lower in active JDM patients and were inversely related to LDH. DLCO values were significantly lower in ANA-positive patients. About half of the patients of this small case series of JDM had asymptomatic lung disease.

Conclusions. We suggest that lung function should be evaluated at disease onset and regularly during follow-up, as pulmonary function tests can detect otherwise unpredictable pulmonary involvement.

KEY WORDS: Juvenile dermatomyositis, Pulmonary function tests.

Notes

Correspondence to: S. Trapani, Department of Paediatrics, Rheumatology Unit, A. Meyer Hospital, Via Luca Giordano 13, 50132 Florence, Italy


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Rheumatology (Oxford)Home page
I. Kobayashi, M. Yamada, Y. Takahashi, N. Kawamura, M. Okano, Y. Sakiyama, and K. Kobayashi
Interstitial lung disease associated with juvenile dermatomyositis: clinical features and efficacy of cyclosporin A
Rheumatology, February 1, 2002; 42(2): 371 - 374.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.